Clinical trial
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents
NCT02542631 is registered in ClinicalTrials.gov with Calibra Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents
- Lead sponsor
- Calibra Medical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2015
- Completion date
- August 31, 2017
- Enrollment
- 278 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.